Agenda
Times are PT
6:30 PM Welcome and Program Overview
6:35 PM Recent Advances in Treatment
6:55 PM Strategies for Individualizing Treatment
7:15 PM Reducing the Impact of Health Inequities
7:30 PM Case Discussion and Question and Answer Session
7:55 PM Closing remarks
8:00 PM Adjournment
Events
Date / Time
Event Details
Faculty
Program Chair
Anita Afzali, MD, MPH, MHCM, FACG, AGAF
Professor of Clinical Medicine
Division of Digestive Diseases
Executive Vice Chair, Department of Internal Medicine
Associate Chief Medical Officer
University of Cincinnati, UC Health System
Cincinnati, Ohio
Faculty
David Hudesman, MD
Associate Professor of Medicine
Gastroenterology
NYU School of Medicine
Co-Director
Inflammatory Bowel Disease Center at NYU Langone
Gastroenterology
NYU Langone Health
New York, New York
Faculty
Millie D. Long, MD, MPH, FACG, AGAF
Professor of Medicine
Director, Gastroenterology and Hepatology Fellowship Program
Vice-Chief for Education
Division of Gastroenterology and Hepatology
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Program Overview
CE-certified education featuring a live 90-minute satellite symposium with downloadable slides and an enduring Webcast. The goal of this activity is to improve learners’ knowledge and competence regarding recent advances in therapy, individualized IBD management, and health inequities affecting patients with IBD.
Goal Statement
The goal of this activity is to improve learners’ knowledge and competence regarding recent advances in therapy, individualized IBD management, and health inequities affecting patients with IBD.
Target Audience
This program is intended for primary care professionals, including physicians, nurse practitioners, physician associates/assistants, and other healthcare professionals who manage patients with IBD.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Detail recent advances in the IBD treatment landscape
- Apply strategies to individualize treatment plans for patients with CD and UC
- Implement strategies to reduce health inequities among patients with IBD
Accreditation
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Designation of Credit
CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.
Physician Associate/Physician Assistant Continuing Medical Education
Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.